Maryland and federal law bar false or misleading OTC drug advertising; ads must not claim cures, FDA approval or prescription strength, or make absolute safety claims beyond the product's labeled uses.
Md. Code, Health-Gen. Title 21, Subtitle 2; Md. Code, Com. Law Sec. 13-301; 21 CFR Part 330; FTC Act Secs. 5, 12, 15
What is MD OTC Drug Marketing - State Board of Pharmacy?
Maryland and federal law bar false or misleading OTC drug advertising; ads must not claim cures, FDA approval or prescription strength, or make absolute safety claims beyond the product's labeled uses. Use on any ad, web, social, email, signage or packaging asset promoting a specific OTC drug to Maryland consumers.
general_audience, general_adults_18plus, customers · OTC Drug · pharma
Where does this rule apply?
Maryland · United States
Which marketing channels are covered?
all_channels
When does this rule take effect?
2026-05-10
What does this rule require?
Maryland and federal law bar false or misleading OTC drug advertising; ads must not claim cures, FDA approval or prescription strength, or make absolute safety claims beyond the product's labeled uses.
How can marketing teams comply?
Use on any ad, web, social, email, signage or packaging asset promoting a specific OTC drug to Maryland consumers.
What is MD OTC Drug Marketing - State Board of Pharmacy?
Maryland and federal law bar false or misleading OTC drug advertising; ads must not claim cures, FDA approval or prescription strength, or make absolute safety claims beyond the product's labeled uses.
Who does this rule apply to?
general_audience, general_adults_18plus, customers · OTC Drug · pharma
Alabama's medical cannabis program (Alabama Medical Cannabis Commission (AMCC)) bars marketing that appeals to minors, promotes non-medical use or reaches people without a patient registration, or makes cure or safety claims.
Arkansas's medical cannabis program (Arkansas Medical Marijuana Commission) bars marketing that appeals to minors, promotes non-medical use or reaches people without a patient registration, or makes cure or safety claims.
Hawaii's medical cannabis program (Hawaii Department of Health — Medical Cannabis Registry) bars marketing that appeals to minors, promotes non-medical use or reaches people without a patient registration, or makes cure or safety claims.
Iowa's medical cannabis program (Iowa Department of Health and Human Services (Iowa HHS), Office of Medical Cannabidiol) bars marketing that appeals to minors, promotes non-medical use or reaches people without a patient registration, or makes cure or safety claims.
Kentucky's medical cannabis program (Kentucky Cabinet for Health and Family Services — Office of Medical Cannabis) bars marketing that appeals to minors, promotes non-medical use or reaches people without a patient registration, or makes cure or safety claims.
Louisiana's medical cannabis program (Louisiana Department of Health — Medical Marijuana Program) bars marketing that appeals to minors, promotes non-medical use or reaches people without a patient registration, or makes cure or safety claims.
Request a free compliance scan of your homepage and book a time with Warrant.